News - Page 95 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

Post published:August 19, 2022
Post category:Press Release

Read more about the article Bright Minds Biosciences Comments on Recent Trading Activity

Bright Minds Biosciences Comments on Recent Trading Activity

Post published:August 18, 2022
Post category:Press Release

Read more about the article Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Post published:August 18, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES EIGHTH PATENT ISSUANCE

FILAMENT HEALTH ANNOUNCES EIGHTH PATENT ISSUANCE

Post published:August 18, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

Post published:August 17, 2022
Post category:Press Release

Read more about the article Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

Post published:August 16, 2022
Post category:Press Release

Read more about the article atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

Post published:August 16, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:August 16, 2022
Post category:Press Release

Read more about the article Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

Post published:August 15, 2022
Post category:Press Release

Read more about the article atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital

atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital

Post published:August 15, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.